(Q44627954)

English

Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery

scientific article published on 20 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

atrial fibrillation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Vassilios Simopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Georgios I Tagarakis

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Stella S Daskalopoulou

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Marios E Daskalopoulos

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Aristidis Lenos

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Konstantinos Chryssagis

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ioannis Skoularingis

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Paschalis-Adam Molyvdas

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Nikolaos B Tsilimingas

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Isaac Aidonidis

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

20 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

294-297

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Atrial fibrillation in patients undergoing surgical revascularization: an update on pharmacologic prophylaxis

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Pharmacological conversion of recent-onset atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Predictors of atrial fibrillation following coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Risk factors for recurrent stroke after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Postoperative atrial fibrillation - what do we really know?

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

The significance of preoperative atrial fibrillation in patients undergoing cardiac surgery: preoperative atrial fibrillation--still underestimated opponent

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Ranolazine: a novel metabolic modulator for the treatment of angina

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Costs and clinical outcomes associated with use of ranolazine for treatment of angina

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

A focus on antiarrhythmic properties of ranolazine

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Perspective: does ranolazine have potential for the treatment of atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Electrophysiological mechanisms underlying rate-dependent changes of refractoriness in normal and segmentally depressed canine Purkinje fibers. The characteristics of post-repolarization refractoriness.

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Tr

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1177%2F0003319713477911

21 January 2018

Identifiers

10.1177/0003319713477911

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44627954&oldid=2029735584"